C5M-30460-13149
3 vaccinations
5 coded responses
17 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 959 / CA
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Dose 1 — Moderna
-
2021-01-27
Dose 2 — Moderna
-
2021-01-28
Registered in v-safe
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Cystitis — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Have an incidental bladder infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
-
2021-02-17
Survey response — day 21, dose 2MedDRA: Abdominal distension, Dysuria, Pelvic discomfort — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Bloating, feeling of fullness, difficulty voiding, pelvic discomfort.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-26
- 2021-03-03
-
2021-03-11
Survey response — day 42, dose 2MedDRA: Ovarian cancer, Unevaluable event — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: New diagnosis of ovarian cancer with metastasis. · Healthcare visit (other): Tomorrow for surgeryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-28
Survey response — 3 months, dose 2MedDRA: Unevaluable event — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Metastatic ovarian cancer diagnosed, debulking surgery, 8 hours on 3/12/21. Pulmonary emboli shower 3 days post op while on lovanox. Started chemotherapy 4/20/21.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-14
-
2021-06-14
Call successfulCompleted over the phone
- 2021-07-28
-
2021-08-31
Dose 3 — Moderna
- 2021-11-30
-
2022-03-01
Survey response — 6 months, dose 3MedDRA: Productive cough, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: FairFree text: Upper respiratory infection with productive cough, no fever, no loss of taste or smell, one week after exposure to my grand daughter and then husband. Home COVID19 test negative.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-08-31 | Moderna | No |
Call center
3 call center cases
3 successful
VAERS report filed, before or during a call: 3
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Have an incidental bladder infection
Release 4 — day 21, dose 2
Symptoms: Bloating, feeling of fullness, difficulty voiding, pelvic discomfort.
Release 5 — day 42, dose 2
Symptoms: New diagnosis of ovarian cancer with metastasis.
Healthcare visit (other): Tomorrow for surgery
Release 8 — 3 months, dose 2
Symptoms: Metastatic ovarian cancer diagnosed, debulking surgery, 8 hours on 3/12/21. Pulmonary emboli shower 3 days post op while on lovanox. Started chemotherapy 4/20/21.
Release 11 — 6 months, dose 3
Symptoms: Upper respiratory infection with productive cough, no fever, no loss of taste or smell, one week after exposure to my grand daughter and then husband. Home COVID19 test negative.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Abdominal distension | ✓ | ✓ | ✓ |
| SD | Dysuria | ✓ | ✓ | ✓ |
| SD | Ovarian cancer | ✓ | ✓ | ✓ |
| SD | Pelvic discomfort | ✓ | ✓ | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Cystitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release